Diabetes Clinical Trials in Chicago

Showing 281-300 of 662 trials

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

NCT03724981

In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.

Diabetes Mellitus, Type 2

Eli Lilly and Company312 participantsStarted Oct 2018

Fresno, California, United States • Long Beach, California, United States • Palm Harbor, Florida, United States +11 more locations

COMPLETEDNA2.2 miles

An Emotion-Focused Intervention for Glycemic Control in T2D

NCT03553680

The primary aim of this proposed project is to collect pilot data using an Emotion-Focused CBT Psycho-social Intervention i individuals with T2D to obtain the effect sizes on hypothesized changes in Negative Emotionality, Diabetes Distress, and HbA1c values that will be needed for a more appropriately sized clinical trial for an RO1 submission to the National Institutes of Health.

Type2 Diabetes

University of Chicago20 participantsStarted Oct 2017

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

NCT03021187

This trial is conducted globally. The aim of the trial is to investigate the efficacy and safety of oral semaglutide versus placebo in subjects with Type 2 Diabetes Mellitus treated with insulin. All subjects should continue their pre-trial insulin therapy (basal, basal-bolus or premixed regimen including combinations of soluble insulins) throughout the trial. Subjects treated with metformin in addition to insulin treatment must continue their metformin treatment throughout the entire trial.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S731 participantsStarted Feb 2017

Anniston, Alabama, United States • Birmingham, Alabama, United States • Fountain Hills, Arizona, United States +115 more locations

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

An Emotion-Focused Intervention for Glycemic Control in T2D

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

Diabetes Trials in Other Cities

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

Rituximab in New Onset Type 1 Diabetes

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas

USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes

Patient and Provider Assessment of Lipid Management Registry

Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Incentivized Smoking Cessation for Diabetics

Assistive ExoSkeletons to Enable Wearable Rehabilitation Robotics

Other Conditions in Chicago